U.S. markets closed
  • S&P Futures

    4,124.75
    -1.75 (-0.04%)
     
  • Dow Futures

    33,718.00
    +15.00 (+0.04%)
     
  • Nasdaq Futures

    13,758.50
    -35.75 (-0.26%)
     
  • Russell 2000 Futures

    2,188.10
    +4.10 (+0.19%)
     
  • Crude Oil

    62.61
    +0.17 (+0.27%)
     
  • Gold

    1,779.10
    +0.70 (+0.04%)
     
  • Silver

    25.86
    +0.02 (+0.08%)
     
  • EUR/USD

    1.2044
    +0.0003 (+0.02%)
     
  • 10-Yr Bond

    1.5620
    -0.0390 (-2.44%)
     
  • Vix

    18.68
    +1.39 (+8.04%)
     
  • GBP/USD

    1.3943
    +0.0006 (+0.04%)
     
  • USD/JPY

    108.0040
    -0.0660 (-0.06%)
     
  • BTC-USD

    56,086.31
    +250.29 (+0.45%)
     
  • CMC Crypto 200

    1,280.65
    +46.23 (+3.75%)
     
  • FTSE 100

    6,859.87
    -140.21 (-2.00%)
     
  • Nikkei 225

    28,730.15
    -370.23 (-1.27%)
     

Last Week's Biotech IPO Recap

Kyle Dennis

Last week, eight biotech companies went public. Some of these companies traded much higher, while others traded lower.

Below is a recap of the IPOs from the week, and a look at how each performed on its first day of trading.

Zosano Pharma Corp (NASDAQ: ZSAN) offered 4.5 million shares on January 27 at $11. After the first day of trading, the stock closed at $11.01.

Ascendis Pharma A/S (NASDAQ: ASND) offered 6 million shares on January 28 at $18. After the first day of trading, the stock closed at $18.83.

Presbia PLC (NASDAQ: LENS) offered 4.2 million shares on January 29 at $10. After the first day of trading, the stock closed at $8.15.

Flex Pharma Inc (NASDAQ: FLKS) offered 5.4 million shares on January 29 at $16. After the first day of trading, the stock closed at $14.95.

Entellus Medical Inc (NASDAQ: ENTL) offered 4.6 million shares on January 29 at $17. After the first day of trading, the stock closed at $22.

TRACON Pharmaceuticals Inc (NASDAQ: TCON) offered 3.6 million shares on January 30 at $10. After the first day of trading, the stock closed at $9.40.

Spark Therapeutics Inc (NASDAQ: ONCE) offered 7 million shares on January 30 at $23. After the first day of trading, the stock closed at $50.

Avinger Inc (NASDAQ: AVGR) offered 5 million shares on January 30 at $14. After the first day of trading, the stock closed at $13.50.

See more from Benzinga

© 2015 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.